The Role of Diet in Patients with Metabolic Syndrome-Reference-Cited by-同舟云学术

The Role of Diet in Patients with Metabolic Syndrome

Published:2019-09-12 Issue:19 Volume:26 Page:3613-3619
ISSN:0929-8673
Container-title:Current Medicinal Chemistry
language:en
Short-container-title:CMC

Author:

Almeda-Valdes Paloma¹,Herrera-Mercadillo Roberto J.¹,Aguilar-Salinas Carlos A.¹,Uribe Misael²,Méndez-Sánchez Nahum²

Affiliation:

1. Department of Endocrinology and Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico

2. Liver Research Unit, Medica Sur Clinic & Foundation. Mexico City, Mexico

Abstract

Metabolic syndrome is a frequent metabolic disorder characterized by obesity and insulin resistance seems to be the main pathophysiological alteration. The goal of treating metabolic syndrome is to reduce the risk of coronary heart disease and the development of type 2 diabetes. The lifestyle modification therapy combines specific recommendations on diet alone or combined with other strategies. In this review, we address the following topics: 1) the importance of the high prevalence of metabolic syndrome and obesity, and 2) the role of lifestyle modification focusing on dietary fat intake in the management of MS.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Reference30 articles.

1. Aguilar M.; Bhuket T.; Torres S.; Liu B.; Wong R.J.; Prevalence of the metabolic syndrome in the United States, 2003-2012. JAMA 2015,313(19),1973-1974

2. Heiss G.; Snyder M.L.; Teng Y.; Schneiderman N.; Llabre M.M.; Cowie C.; Carnethon M.; Kaplan R.; Giachello A.; Gallo L.; Loehr L.; Avilés-Santa L.; Prevalence of metabolic syndrome among Hispanics/Latinos of diverse background: The Hispanic Community Health Study/Study of Latinos. Diabetes Care 2014,37(8),2391-2399

3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002,106(25),3143-3421

4. Ng M.; Fleming T.; Robinson M.; Thomson B.; Graetz N.; Margono C.; Mullany E.C.; Biryukov S.; Abbafati C.; Abera S.F.; Abraham J.P.; Abu-Rmeileh N.M.; Achoki T.; AlBuhairan F.S.; Alemu Z.A.; Alfonso R.; Ali M.K.; Ali R.; Guzman N.A.; Ammar W.; Anwari P.; Banerjee A.; Barquera S.; Basu S.; Bennett D.A.; Bhutta Z.; Blore J.; Cabral N.; Nonato I.C.; Chang J.C.; Chowdhury R.; Courville K.J.; Criqui M.H.; Cundiff D.K.; Dabhadkar K.C.; Dandona L.; Davis A.; Dayama A.; Dharmaratne S.D.; Ding E.L.; Durrani A.M.; Esteghamati A.; Farzadfar F.; Fay D.F.; Feigin V.L.; Flaxman A.; Forouzanfar M.H.; Goto A.; Green M.A.; Gupta R.; Hafezi-Nejad N.; Hankey G.J.; Harewood H.C.; Havmoeller R.; Hay S.; Hernandez L.; Husseini A.; Idrisov B.T.; Ikeda N.; Islami F.; Jahangir E.; Jassal S.K.; Jee S.H.; Jeffreys M.; Jonas J.B.; Kabagambe E.K.; Khalifa S.E.; Kengne A.P.; Khader Y.S.; Khang Y.H.; Kim D.; Kimokoti R.W.; Kinge J.M.; Kokubo Y.; Kosen S.; Kwan G.; Lai T.; Leinsalu M.; Li Y.; Liang X.; Liu S.; Logroscino G.; Lotufo P.A.; Lu Y.; Ma J.; Mainoo N.K.; Mensah G.A.; Merriman T.R.; Mokdad A.H.; Moschandreas J.; Naghavi M.; Naheed A.; Nand D.; Narayan K.M.; Nelson E.L.; Neuhouser M.L.; Nisar M.I.; Ohkubo T.; Oti S.O.; Pedroza A.; Prabhakaran D.; Roy N.; Sampson U.; Seo H.; Sepanlou S.G.; Shibuya K.; Shiri R.; Shiue I.; Singh G.M.; Singh J.A.; Skirbekk V.; Stapelberg N.J.; Sturua L.; Sykes B.L.; Tobias M.; Tran B.X.; Trasande L.; Toyoshima H.; van de Vijver S.; Vasankari T.J.; Veerman J.L.; Velasquez-Melendez G.; Vlassov V.V.; Vollset S.E.; Vos T.; Wang C.; Wang X.; Weiderpass E.; Werdecker A.; Wright J.L.; Yang Y.C.; Yatsuya H.; Yoon J.; Yoon S.J.; Zhao Y.; Zhou M.; Zhu S.; Lopez A.D.; Murray C.J.; Gakidou E.; Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014,384(9945),766-781

5. Grams J.; Garvey W.T.; Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep 2015,4(2),287-302

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001–2018;Cardiovascular Diabetology;2024-07-10

2. Cereal-based foods for people with special needs: focus on celiac disease and metabolic syndrome;Handbook of Plant-Based Food and Drinks Design;2024

3. Effects of an Individualized mHealth-Based Intervention on Health Behavior Change and Cardiovascular Risk Among People With Metabolic Syndrome Based on the Behavior Change Wheel: Quasi-Experimental Study;Journal of Medical Internet Research;2023-11-29

4. Effects of an Individualized mHealth-Based Intervention on Health Behavior Change and Cardiovascular Risk Among People With Metabolic Syndrome Based on the Behavior Change Wheel: Quasi-Experimental Study (Preprint);2023-05-23

5. The Impact of the Hypercaloric Diet versus the Mediterranean Diet on Insulin Sensitivity;Romanian Journal of Military Medicine;2023-01-08